SCHEMBL6987053

SCHEMBL6987053

OCCc1cc(Cl)nc(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALOX5 P09917 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
BACE1 P56817 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
CA2 P00918 2/20 0.37
S1PR2 O95136 1/20 0.37
FFAR1 O14842 1/20 0.36
POLB P06746 1/20 0.34
PDE4B Q07343 1/20 0.33
MAPK14 Q16539 1/20 0.33
CDK8 P49336 1/20 0.33
HTT P42858 1/20 0.32
LOX P28300 1/20 0.31
LOXL3 P58215 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7349175 0.85 MAPK1 (0.36) RECQLTDP1ALDH1A1KDM4EALOX5
SCHEMBL15390929 0.80 ADORA2A (0.34) RECQLTDP1ALDH1A1KDM4EALOX5
SCHEMBL904515 0.79 RECQL (0.54) RECQLTDP1KDM4ECYP2D6CYP2C19
SCHEMBL24738810 0.75 CYP2D6 (0.37) RECQLCYP2D6CYP2C19S1PR2POLB
SCHEMBL31047280 0.75 RECQL (0.40) RECQLCYP2D6CYP2C19S1PR2FFAR1
SCHEMBL27704309 0.75 TDP1 (0.39) RECQLTDP1S1PR2FFAR1LOX
SCHEMBL5751544 0.75 ALDH1A1 (0.45) RECQLALDH1A1KDM4EGAAMAPT
SCHEMBL6987047 0.75 S1PR2 (0.37) RECQLALDH1A1S1PR2FFAR1LOX
SCHEMBL15517369 0.75 FFAR1 (0.33) RECQLS1PR2FFAR1LOXLOXL3
SCHEMBL63871 0.74 TDP1 (0.53) TDP1ALDH1A1KDM4EALOX5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299379-A2 LACTAM METALLOPROTEASE INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-04-09 EP disclosed
WO-2002004416-A2 LACTAM METALLOPROTEASE INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-17 WO disclosed